Longevity of antibody responses is associated with distinct antigen-specific B cell subsets early after infection

Front Immunol. 2024 Dec 17:15:1505719. doi: 10.3389/fimmu.2024.1505719. eCollection 2024.

Abstract

Introduction: Upon infection, T cell-driven B cell responses in GC reactions induce memory B cells and antibody-secreting cells that secrete protective antibodies. How formation of specifically long-lived plasma cells is regulated via the interplay between specific B and CD4+ T cells is not well understood. Generally, antibody levels decline over time after clearance of the primary infection.

Method: In this study, convalescent individuals with stable RBD antibody levels (n=14, "sustainers") were compared with donors (n=13) with the greatest antibody decline from a cohort of 132. To investigate the role of the cellular immune compartment in the maintenance of antibody levels, SARS-CoV-2-specific responses at 4 to 6 weeks post-mild COVID-19 infection were characterized using deep immune profiling.

Results: Both groups had similar frequencies of total SARS-CoV-2-specific B and CD4+ T cells. Sustainers had fewer Spike-specific IgG+ memory B cells early after infection and increased neutralizing capacity of RBD antibodies over time, unlike the declining group. However, declining IgG titers correlated with lower frequency of Spike-specific CD4+ T cells.

Conclusion: These data suggest that "sustainers" have unique dynamics of GC reactions, yield different outputs of terminally differentiating cells, and improve the quality of protective antibodies over time. This study helps identify factors controlling formation of long-lived PC and sustained antibody responses.

Keywords: CD4+ T cells; SARS-CoV-2; declining/sustained antibody titers; deep-phenotyping; neutralization.

MeSH terms

  • Adult
  • Antibodies, Neutralizing / blood
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral* / blood
  • Antibodies, Viral* / immunology
  • Antibody Formation / immunology
  • B-Lymphocyte Subsets / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • COVID-19* / immunology
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Memory B Cells / immunology
  • Middle Aged
  • SARS-CoV-2* / immunology
  • Spike Glycoprotein, Coronavirus / immunology

Substances

  • Antibodies, Viral
  • Spike Glycoprotein, Coronavirus
  • Antibodies, Neutralizing
  • Immunoglobulin G
  • spike protein, SARS-CoV-2

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was funded by Sanquin Blood Supply project grant PPOC, project number L2506. This research project was supported by ZonMw (The Netherlands Organization for Health Research and Development) project number #10430072010007. CK has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement no. 860003.